Clinical characteristics of non-perianal fistulating Crohn's disease in China: a single-center experience of 184 cases
- PMID: 22882911
Clinical characteristics of non-perianal fistulating Crohn's disease in China: a single-center experience of 184 cases
Abstract
Background: There is little information of non-perianal fistulating Crohn's disease in the consensus published by the European Crohn's and Colitis Organization in 2006 and 2010. This study was designed to demonstrate the clinical characteristics of non-perianal fistulating Crohn's disease among homogenous Chinese population.
Methods: One-hundred-and-eighty-four patients were retrospectively collected. All of these patients were diagnosed of Crohn's disease between February 2001 and April 2011.
Results: The male-to-female ratio was 2.7:1. The most common symptoms at onset were abdominal pain (88.0%), diarrhea (34.7%), and fever (28.3%). The most common disease location and behavior at diagnosis were small bowel (56.0%) and penetrating (51.6%). Among 324 non-perianal fistulae, the most common types were ileocolonic anastomotic (30.9%), terminal ileocutaneous (19.7%), and enteroenteric anastomotic (11.4%). One-hundred-and-thirty- eight (75.0%) patients received antibiotics, and β-lactam (85.5%) and metronidazole (67.4%) are most frequently used. One-hundred-and-seventy-eight (96.7%) patients suffered 514 surgical operations, and the cumulative surgical rates after 1, 3, and 5 years were 38.0%, 52.2%, and 58.7% respectively. Nine patients died during the follow-up period, and the cumulative survival rates after 1, 3, and 5 years were 97.8%, 96.7%, and 96.2% respectively.
Conclusions: This study displayed the clinical characteristics of non-perianal fistulating Crohn's disease in our center. Large population-based studies are required for further investigation in China.
Similar articles
-
Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment.Dis Colon Rectum. 2006 Dec;49(12):1837-41. doi: 10.1007/s10350-006-0656-5. Dis Colon Rectum. 2006. PMID: 17041753
-
Combined modality treatment for complex fistulating perianal Crohn's disease.Colorectal Dis. 2013 Feb;15(2):210-6. doi: 10.1111/j.1463-1318.2012.03124.x. Colorectal Dis. 2013. PMID: 22672653
-
The spectrum of perianal Crohn's disease in a population-based cohort.Dis Colon Rectum. 2012 Jul;55(7):773-7. doi: 10.1097/DCR.0b013e31825228b0. Dis Colon Rectum. 2012. PMID: 22706129
-
Perianal inflammatory conditions in inflammatory bowel disease.Curr Opin Gen Surg. 1993:141-6. Curr Opin Gen Surg. 1993. PMID: 7583950 Review.
-
Adenocarcinoma arising from chronic perianal Crohn's disease: case report and review of the literature.Am Surg. 2008 Jan;74(1):59-61. Am Surg. 2008. PMID: 18274431 Review.
Cited by
-
Indicators for early surgery in patients with intra-abdominal fistulizing Crohn's disease.Ann Saudi Med. 2025 May-Jun;45(3):182-189. doi: 10.5144/0256-4947.2025.182. Epub 2025 Jun 5. Ann Saudi Med. 2025. PMID: 40482192 Free PMC article.
-
Clinical features of Crohn disease concomitant with ankylosing spondylitis: A preliminary single-center study.Medicine (Baltimore). 2016 Jul;95(28):e4267. doi: 10.1097/MD.0000000000004267. Medicine (Baltimore). 2016. PMID: 27428240 Free PMC article.
-
Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn's disease.Eur J Clin Nutr. 2014 Apr;68(4):441-6. doi: 10.1038/ejcn.2014.16. Epub 2014 Feb 19. Eur J Clin Nutr. 2014. PMID: 24549026
-
The effect of miRNA and autophagy on colorectal cancer.Cell Prolif. 2020 Oct;53(10):e12900. doi: 10.1111/cpr.12900. Epub 2020 Sep 10. Cell Prolif. 2020. PMID: 32914514 Free PMC article. Review.
-
Fermented herbal formula KIOM-MA-128 protects against acute colitis induced by dextran sodium sulfate in mice.BMC Complement Altern Med. 2017 Jul 5;17(1):354. doi: 10.1186/s12906-017-1855-4. BMC Complement Altern Med. 2017. PMID: 28679372 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous